Neuberger Berman Group’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.86M Buy
150,805
+145,737
+2,876% +$5.39M ﹤0.01% 988
2025
Q4
$213K Buy
+5,068
New +$204K ﹤0.01% 1932
2025
Q1
Sell
-5,073
Closed -$201K 2063
2024
Q4
$201K Buy
+5,073
New +$192K ﹤0.01% 1801
2021
Q1
Sell
-81,750
Closed -$4M 1823
2020
Q4
$4M Buy
81,750
+36,750
+82% +$1.7M ﹤0.01% 962
2020
Q3
$1.46M Sell
45,000
-25,000
-36% -$795K ﹤0.01% 1121
2020
Q2
$1.81M Hold
70,000
﹤0.01% 1017
2020
Q1
$1.7M Hold
70,000
﹤0.01% 984
2019
Q4
$1.95M Buy
70,000
+14,100
+25% +$365K ﹤0.01% 1034
2019
Q3
$1.34M Buy
55,900
+14,400
+35% +$383K ﹤0.01% 1090
2019
Q2
$1.18M Buy
41,500
+21,500
+108% +$537K ﹤0.01% 1130
2019
Q1
$500K Sell
20,000
-22,634
-53% -$432K ﹤0.01% 1253
2018
Q4
$536K Sell
42,634
-52,366
-55% -$619K ﹤0.01% 1246
2018
Q3
$907K Buy
+95,000
New +$1.05M ﹤0.01% 1211

Other funds holding VCYT

Neuberger Berman Group's VCYT Position: Q1 2026 in Review

Neuberger Berman Group increased its Veracyte (VCYT) stake by 2,876% in Q1 2026, buying an estimated $5.39M and bringing the position to 150,805 shares worth $4.86M. The position accounts for ﹤0.01% of the portfolio, ranked #988.

Neuberger Berman Group first reported a position in VCYT in Q3 2018 and has held it in 13 quarters since. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Neuberger Berman Group held 150,805 shares of Veracyte worth $4.86M as of Q1 2026.
  • Neuberger Berman Group bought 145,737 Veracyte shares in Q1 2026, an estimated $5.39M.
  • Veracyte made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #988 holding.
  • Neuberger Berman Group first reported a position in Veracyte in Q3 2018 and has held it in 13 quarters since.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.